Metraipolis › archive › dc_b86166bfad57

AI-driven de novo design of BRAF inhibitors with enhanced binding affinity and optimized drug-likeness — Europe PMC PMID:41497266

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41497266
DOI
10.7717/peerj.20541
License (as archived)
solo-consultazione
Archived
2026-10-07T21:05:16.857Z
SHA-256 of the archived text
ef19bbbbeee14bf30bbb36d7056c36be2017a899fba40ee7ad05aeb3ed9193da
Stable URL of this page
https://metraipolis.com/documento/dc_b86166bfad57

How to cite

AI-driven de novo design of BRAF inhibitors with enhanced binding affinity and optimized drug-likeness — Europe PMC PMID:41497266 — Europe PMC (en), https://europepmc.org/article/MED/41497266 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b86166bfad57 (Metraipolis archive dc_b86166bfad57, sha256 ef19bbbbeee14bf30bbb36d7056c36be2017a899fba40ee7ad05aeb3ed9193da)
BibTeX
@misc{dcb86166bfad57,
  title = {AI-driven de novo design of BRAF inhibitors with enhanced binding affinity and optimized drug-likeness — Europe PMC PMID:41497266},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41497266},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b86166bfad57; sha256 ef19bbbbeee14bf30bbb36d7056c36be2017a899fba40ee7ad05aeb3ed9193da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41497266. Agents can read the archived copy with the MCP tool read_document.